Mustafa Solak, MD est un médecin diplômé de l'École de médecine de l'Université Hacettepe et a effectué des résidences à l'hôpital d'enseignement et de recherche Sisli Etfal d'Istanbul et une bourse à l'Institut du cancer de l'Université Hacettepe. Il se spécialise dans le cancer du sein, le cancer des testicules, le cancer de l'ovaire, le cancer du poumon, le cancer de la tête et du cou et les cancers gastro-intestinaux. Il a également travaillé au MD Anderson Cancer Center de l'Université du Texas, au Hitit University Corum Training Hospital et au Medical Park Hospital.
Lire la suiteVisite du médecin | prix sur demande |
Chirurgie de Whipple | $14500 - $15000 |
Chimiothérapie | $1500 - $2500 |
Résection thyroïdienne | $5000 - $7500 |
Le Dr Tarık Akar est diplômé de l'École de médecine Cerrahpaşa de l'Université d'Istanbul en 2000 et a obtenu le titre d'« Interniste » en 2004. Il a publié 19 articles internationaux, 6 articles locaux et 25 présentations lors de congrès locaux et internationaux. Ses domaines d'intérêt médical comprennent l'achalasie, l'ESD, la CPRE, le diverticule de Zenker et la gastroparésie.
Lire la suiteVisite du médecin | prix sur demande |
Chirurgie de Whipple | $14500 - $15000 |
Chimiothérapie | $1500 - $2500 |
Résection thyroïdienne | $5000 - $7500 |
Dr. Sertkaya graduated from Konya Meram Science High School in 2001 and entered Gazi University Medical Faculty the same year, graduating in 2008. He completed his urology specialization at Haydarpaşa Numune Training and Research Hospital in 2014, becoming a urology specialist.
Since becoming a specialist, he has focused on the sub-branch of Andrology, attending various training sessions and conferences and performing surgeries with some of the world's leading Andrology professors. In 2017, he passed the written and oral proficiency exams conducted by the European Association of Urology, earning the title of "FEBU."
In 2020, Dr. Sertkaya achieved the rank of Associate Professor of Urology. His journey in Urology and Andrology, which began in 2008, continues at the Andro Expertise Male Health and Aesthetics Center, which he founded in 2022. He sees patients in his own clinic and performs surgeries at affiliated hospitals.
Lire la suiteEğitim:
Uzmanlık Eğitimi ve Deneyim:
Akademik Kariyer:
2011 – 2015, (Internal Medicine Specialist) Istanbul University Istanbul School of Education and Career
Medicine Department of Internal Medicine
2015 – 2016, (Internal Medicine) Specialist Istanbul Haydarpasa Numune Training and Research Hospital
2016 – 2019, (Medical Oncology) Istanbul University Istanbul School of Medicine Department of Medical Oncology
2019 – 2021, (Medical Oncology Specialist) - Istanbul Haydarpasa Numune Training and Research Hospital
2021 – 2024, (Associate Professor) Marmara University School of Medicine Department of Medical Oncology
Memberships in Scientific Organizations
ASCO
ESMO
TTOD
AVOD
Publications
In the field of oncology, he has published over 30 peer-reviewed articles at both international and national levels.
Awards Received
EAACI The European Academy of Allergy and Clinical Immunology 2019 Best Poster Award
"The top 3rd verbal presentation, IGICC (11th International Gastrointestinal Cancers Conference – IGICC2021)"
Speeches Delivered at National Congresses, Conferences, and Symposia:
Courses, Meetings, and Certificates
ESMO certified Medical Oncologist since 2019
Lire la suiteExperience:
2022 -
Medipol Bahçelievler
2021 - 2022
MEDIPOL UNIVERSITY SEFAKÖY HOSPITAL
2018 - 2020
İSTİNYE UNIVERSITY FACULTY OF MEDICINE
2014 - 2020
TOKAT STATE HOSPITAL
2010 - 2010
BINGOL STATE HOSPITAL
Education:
2021
MEDIPOL UNIVERSITY, GASTROTEROLOGY
2018
İSTINYE UNIVERSITY, INTERNAL DISEASES USA
2014
ANKARA TRAINING AND RESEARCH HOSPITAL, GASTROENTEROLOGY
2010
FIRAT UNIVERSITY, FACULTY OF MEDICINE/INTERNAL MEDICAL SCIENCES DEPARTMENT/INTERNAL MEDICINE DEPARTMENT
2004
FIRAT UNIVERSITY, FACULTY OF MEDICINE
A. International Peer-Reviewed Journal Articles:
Title: Fatal fulminant hepatitis B after withdrawal of entecavir treatment in a patient with HBeAg seroconversion.
Title: Acute gastric obstruction resulting from gallstone-induced bezoar.
Title: Garlic-induced esophagitis.
Title: Association between Helicobacter pylori and liver-to-spleen ratio.
Title: Crohn's disease masked by median arcuate ligament syndrome.
Title: Telaprevir and anemia: What we learned from the first three patients.
Title: Magnesium and parathyroid hormone levels of patients using different proton pump inhibitors.
Title: Is topical pharyngeal anesthesia necessary in esophagogastroduodenoscopy in all unsedated patients?
Title: Inpatient Care Of Hepatitis C: Applying The Four Pillars Model To The Hospital Setting.
Title: "The "Bouveret's Syndrome" Case Resolved Without Necrotic Changes."
Title: Severe acute pancreatitis due to hypertriglyceridemia.
Title: Gallstone Ileus Caused by Cholecystoenteric Fistula Demonstrated on Computed Tomography.
Title: Intestinal Perforation Due to Ingested Chicken Bone Mimicking Crohn's Disease.
Title: Acute pancreatitis induced by hypertriglyceridemia: A case-based review.
Title: An Unusual Complication of Endoscopic Retrograde Cholangiopancreatography: Severe Acute Pancreatitis Leading to Death.
Title: A Rare Cause of Abdominal Pain: Mesenteric Panniculitis.
B. Contributions to Scientific Conferences:
Title: Suicidal poisonings in Turkey: demographic and clinical aspects.
Title: A Rare Cause of Gastrointestinal Bleeding: Aortoenteric Fistula.
Visite du médecin | prix sur demande |
Thérapie à l'iode radioactif | $5000 - $7000 |
Radiothérapie pour une tumeur cérébrale | $4000 - $6000 |
Mastectomie | $5000 - $7500 |
Visite du médecin | prix sur demande |
Chirurgie de Whipple | $14500 - $15000 |
Chimiothérapie | $1500 - $2500 |
Résection thyroïdienne | $5000 - $7500 |
Education:
Akdeniz University Faculty of Medicine
Specialization Training:
Baskent University Faculty of Medicine. Internal diseases
Akdeniz University Faculty of Medicine, Gastroenterology Minor
Worked Institutions:
Tekirdag State Hospital (Compulsory Service)
Demiroğlu Bilim University Faculty of Medicine, Gastroenterology
Medical Interests:
Endoscopy-Colonoscopy
ERCP
Hepatology
Inflammatory Bowel Diseases
Liver Transplantation
Lire la suiteUNIVERSITÉ
Faculté de médecine de l'Université d'Ankara
UNIVERSITÉ OÙ IL PREND SA EXPERTISE
Chirurgie générale de l'hôpital de formation et de recherche de Göztepe
CONGRÈS PARTICIPÉS
Congrès national de chirurgie endoscopique et laparoscopique
Congrès mondial sur les controverses en vue d'un consensus sur le diabète, l'obésité et l'hypertension
Congrès de Chirurgie Bariatrique et Métabolique
Réunions de chirurgie de Cerrahpaşa Association turque de chirurgie bariatrique
Lire la suite
PROFESSIONAL EXPERIENCE
2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine
2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine
06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine
10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship
2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship
2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist
2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.
EDUCATION
2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey
2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey
2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey
2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey
2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.
2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey
INTERNATIONAL CLINICAL TRIALS:
1. Astefania - ROCHE
2. PFİZER
3. RECITE - AMGEN
4. NAVIGATE - BAYER
5. RUBY - Tesaro (PRA)
6. ENGOT-ov43/GOG-3036 - MSD
7. ASTRA ZENECA
8. ROSY-O - ASTRA ZENECA
INTERNATIONAL PUBLICATIONS
I. Published journal articles indexed by SCI, SSCI, and AHCI
Weekly Paclitaxel in Classic Kaposi Sarcoma
Carboplatin Desensitization in Ovarian Carcinoma
High-Dose Chemotherapy for Ewing’s Sarcoma
Multidrug Refractory TFE3(+) Renal Cell Carcinoma
Crizotinib Efficacy in NSCLC with MET Alterations
Clinicopathological Features in ALK Mutant NSCLC
PSMA-Based Tumor Burden in Prostate Cancer
Atezolizumab in Metastatic Urothelial Carcinoma
Pulmonary Sarcomatoid Carcinoma
Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma
Atezolizumab with Chemotherapy in Small Cell Lung Cancer
FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer
Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients
Real-Life Efficacy of Osimertinib in Advanced NSCLC
ALK-Positive Cells Percentage and Alectinib Efficacy
Real-World Data on Alectinib in ALK-Positive NSCLC
Prognostic Factors in Metastatic RCC with T790M Mutation
FLOT Regimen in Metastatic Gastric Cancer
Desensitization Protocol in Lenalidomide Hypersensitivity Reactions
Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity
Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors
Subsequent Treatments in Hormone-Positive Breast Cancer Progression
Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer
Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer
Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer
Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer
Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients
Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients
Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases
FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer
Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer
Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma
Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma
Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)
Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)
Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.
Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49
Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4
Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.
Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology
Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)
Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)
Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)
Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)
Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
Thesis:
Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)
International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)
Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination
Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer
Efficacy of temozolomide in pretreated patients with metastatic sarcoma
Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors
Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases
Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma
Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study
Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences
Lire la suite
Visite du médecin | prix sur demande |
Thérapie à l'iode radioactif | $5000 - $7000 |
Radiothérapie pour une tumeur cérébrale | $4000 - $6000 |
Mastectomie | $5000 - $7500 |
Gastro-entérologie
Pendik Medipol University Hospital
1999 Université technique de Karadeniz, Gastro-entérologie
1997Université d'Atatürk, chaire de maladies internes
1992 Atatürk University, Professeur associé en maladies internes
1985 Atatürk University, Internal Diseases Specialist
1981 Atatürk University Faculty of Medicine
1- Nihat Okçu Gülçin Polat,Arif Yılmaz,Mehmet Koruk,The demographıc features of gastrıc cancers in erzurum(Eurasian J Med 2000 ; 32 : 63-65)
2- An Evaluation of Cases with Upper Gastrointestinal Bleeding. Klinik Bilimler-Doktor.2000, - E.akarsu,N.Okçu, ve Ark.Kuzeydoğu Anadolu'da 6:4:435-438
3-N.Okçu, A.yılmaz. İ.kiki,M.D.onuk, C.gündoğdu, H.uzunismail. Résultats de l'endoscopie diagnostique du tractus gastro-intestinal supérieur. Atatürk University Medical Journal 1997,29 (2):486
4-N. Okçu, M.gündoğdu, M.D. onuk, İ.kiki, l.cerrahoğlu, k.yılmaz, i.çapoğlu. The Role of Misoprostol in the Prevention of Gastroduodenal Lesions in Patients Using Nonsteroidal Anti Inflammatory Drugs (NSAIDs) (Le rôle du misoprostol dans la prévention des lésions gastroduodénales chez les patients utilisant des anti-inflammatoires non stéroïdiens). Atatürk University Medical Journal 1997,29 (2):453-455.
5-N.Okçu, A. öz, m.d. onuk, e.akarsu, b. tekin, h.z. tonbul, h.kaya. Plasma Fibronectin Levels in Decopansed Liver Parenchymal Failure with Chronic Active Hepatitis and Its Relationship with Liver Function Status. Turkish J. Gastroenterol 1995;27(4) : 422-426.
6-N.Okçu, tahir buran,m.d. onuk,a. yılmaz, e.akarsu, g. akçay. Prevalence of Helicobacter Pylori in Patients with Duodenal Ulcer in Erzurum and Surroundings (Prévalence d'Helicobacter Pylori chez les patients atteints d'ulcère duodénal à Erzurum et dans les environs). Türk J. Gastroenterol 1995;27(4) : 447-450.
7-N.Okçu, b.s. uyanık, e. akarsu, e. bakan, z. tonbul. The Importance of Carbohydrate Antigens (CA-19-9, CA-125), Carcinoembryonic Antigen (CEA) and Alkaline Phosphatase in Gastric and Colorectal Cancers. Türk J. Gastroenterol 1995;6:467-471.
8-N. Okçu, m.d. onuk, e. akarsu, h. doğan, c. gündoğdu. Major Risk Factors in Patients with Hepatocellular Carcinoma in Our Region. Gastroenterology 1994;5(2):154-157
9-N.Okçu, m.d. onuk, e. akarsu, h. doğan, c.gündoğdu, tahir buran. Gastric Carcinoma Frequency, Endoscopic and Histological Features in Erzurum Region (Fréquence des carcinomes gastriques, caractéristiques endoscopiques et histologiques dans la région d'Erzurum). Gastroenterology 1994;5(2):263-267.
10-N. Okçu, m.d. onuk, tahir buran, e. akarsu, m.a. çiftçioğlu. The Prevalence of Helicobacter Pylori in Cases with Nonspecific Gastritis in the Surroundings of Erzurum Province. Gastroenterology 1994;5(2):211-213.
11-N.Okçu, m.d. onuk, ö. unal, e. akarsu, l. incesu, k. akgöz. Valeur diagnostique de la biopsie par aspiration à l'aiguille fine guidée par échographie dans les lésions de masse intra-abdominales. Gastroenterology 1993;4(1):166-68.
12-N.O.kçu, m.d. onuk, m. polat, a. yılmaz, m. gündoğdu, m. paç. Budd-Chiari Syndrome (2 cas). Türk J Gastroenterhepatol 1993 ; 4(1):77-80.
13-N.Okçu, h. koçak, m.d. onuk, m. gündoğdu, e. bakan, a. yılmaz, a. başoğlu, a. ateş, f.a. paç. The Effect of Atrial Pressure Changes and Cardiac Nerves on Plasma Atrial Natriuretic Peptide (ANP) Levels. Vascular Surgery 1993 ; 27(2) : 128-132
15-N.Okçu, m.d. onuk, a.yılmaz, m. gündoğdu, t. buran. Effets de l'oméprozole et de la ranitidine sur la cicatrisation de l'ulcère gastroduodénal. Doğa-Tr.J. of Medical Sciences 1992;16:657-658.
16-N. Okçu, m.r. yiğitoğlu, b. adam, e. bakan. The Effect of Digixin on Plasma Atrial Natriuretic Peptide Levels in Patients with Congestive Heart Failure (L'effet de Digixin sur les niveaux plasmatiques de peptide natriurétique auriculaire chez les patients atteints d'insuffisance cardiaque congestive). S.Ü. Tıp Fak. Journal 1991;7(2):243-247..
17-N.Okçu, a. yılmaz. The Effect of Histamine H2 -Receptor Antagonists in Upper Gastrointestinal System Haemorrhages. Endoscopy Journal 1991;2(4):17-23.
18-N.Okçu, E. bakan, b. adam, a. yılmaz, m.r. yiğitoğlu. Sex Hormones and Sex Hormone Binding Globulin Levels in Patients with Chronic Hepatitis and Liver Cirrhosis (Letter to the Editor). Doga-Tr. J. Of Medical Sciences 1991;15:1-2.
19-N.Okcu Ömer Yılmaz.Helıcobacter pylori and related gastroıntestınal system dıseases Turkiye Klinikleri JMed Sci. 2013;33(3):806-13
20-Nihat Okçu , Ömer yılmaz, hakan dursun, gülçin polat. La relation entre les symptômes dyspeptiques et les habitudes alimentaires, les résultats endoscopiques et histologiques (Eurasian J Med 2006 ; 38 : 13-17)
21-Mehmet Bilici,1Nihat Okcu,1Kerim Cayır,1Ibrahim Pirim,2Salim B. Tekin,1etCemal Gundogdu3 - Distribution des groupes de tissus HLA chez les patients atteints de cancer de l'estomac Eurasian J Med. 2010 Apr ; 42(1) : 9.11.
22-Nihat Okcu,Abdulhalim Bak,Mehmet Sari,Mehmet Arslan,Sait Kapicioglu :La prolifération des fibroblastes, la relation entre le facteur de croissance des hépatocytes (HGF) et l'interféron-A2A Gastroenterology April 2000Volume 118,Issue 4, Part 2, PageA1404
23-Kubra Kaynar,Sait Kapicioglu,Mehmet Sari,Nihat Okcu,Abdulhalim Baki. L'effet de l'huile de poisson sur la prophylaxie de l'ulcère de stress GastroenterologyVolume 118, Issue 4, Part 2, PageA1255
Lire la suiteRadio-oncologue agréé avec 8 ans de formation médicale, y compris des études de premier cycle à la Faculté de médecine de l'Université de Marmara (2004-2011) et une formation de spécialisation en radio-oncologie à la Faculté de médecine de l'Université de Marmara (2012-2016). Études antérieures au lycée Shirvan à seize numéros (Azerbaïdjan) (1998-2004).
Lire la suiteVisite du médecin | prix sur demande |
Chimiothérapie pour le cancer du poumon | $1500 - $3700 |
Chimiothérapie pour le cancer du pancréas | $1500 - $4500 |
Chirurgie du cancer de la langue | $19000 |